Feb. 5, 2018 - Varian (NYSE: VAR) today announced it has acquired privately-held Mobius Medical Systems®, a leader in radiation oncology Quality Assurance (QA) software.
Varian (NYSE: VAR) announced that it will discuss the details of the M&A agreement, to acquire all the outstanding shares of Sirtex Medical Limited (ASX: SRX) ("Sirtex"). Sirtex is an Australia-based global life sciences company focused on interventional oncology therapies, that is listed on the Australian Securities Exchange.
The Halcyon™ system is Varian’s newest cancer treatment device, engineered to simplify and enhance virtually every aspect of image-guided volumetric intensity-modulated radiotherapy (IMRT). Halcyon combines fast volumetric imaging and dose delivery with the power of Eclipse™ treatment planning system in a transformative platform.
TrueBeam system brings leading edge cancer care to communities by positioning clinics at the forefront in the fight against cancer. Designed from the ground up to treat moving targets with advanced speed and accuracy, the TrueBeam platform is a fully-integrated system for image-guided radiotherapy and radiosurgery.
Novalis Radiosurgery strengthens the strategic position of facilities dedicated to a comprehensive and focused vision for excellence in targeted cancer treatments.